601375:SSECentral China Securities Co Ltd Class A Analysis
Data as of 2026-03-14 - not real-time
CN¥4.25
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Central China Securities is currently trading at a price‑to‑earnings multiple that is substantially higher than the average for its capital‑markets peers. This premium is not supported by its modest revenue growth and thin profit margins. The company's operating and net margins hover just above the low‑30% range, indicating limited pricing power. Although it holds a strong cash pile, the balance sheet is weighed down by debt that more than doubles its equity, raising concerns about leverage. The dividend yield is low, but the payout ratio remains modest, suggesting the dividend is currently sustainable. Overall, the fundamental picture points to a stock that is priced for limited upside unless earnings accelerate or valuation multiples compress.
Technically, the 20‑day and 50‑day moving averages are tightly clustered below the current price, and the price sits near a recent support zone. The MACD line sits below its signal, delivering a bearish signal that aligns with the overall downtrend. RSI sits in the neutral zone, offering no immediate momentum boost. Volume has been rising, adding pressure to the price as sellers become more active. The stock exhibits low beta, meaning it moves less than the broader market, yet recent volatility has been elevated, contributing to a moderate risk profile. Given the mix of overvaluation, bearish technicals, and a solid cash base, a cautious stance is warranted, with short‑term investors advised to stay on the sidelines while longer‑term holders may look for a catalyst to justify the price.
Technically, the 20‑day and 50‑day moving averages are tightly clustered below the current price, and the price sits near a recent support zone. The MACD line sits below its signal, delivering a bearish signal that aligns with the overall downtrend. RSI sits in the neutral zone, offering no immediate momentum boost. Volume has been rising, adding pressure to the price as sellers become more active. The stock exhibits low beta, meaning it moves less than the broader market, yet recent volatility has been elevated, contributing to a moderate risk profile. Given the mix of overvaluation, bearish technicals, and a solid cash base, a cautious stance is warranted, with short‑term investors advised to stay on the sidelines while longer‑term holders may look for a catalyst to justify the price.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 4/10
Key Factors
- bearish MACD signal
- price near recent support
- increasing selling volume
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- valuation well above industry peers
- modest revenue growth
- low beta reduces market volatility exposure
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- substantial cash reserves
- potential for regulatory easing
- sustainable dividend despite low yield
Key Metrics & Analysis
Financial Health
Revenue Growth509.70%
Profit Margin25.87%
P/E Ratio42.5
ROE3.28%
ROA0.86%
Debt/Equity129.25
P/B Ratio1.4
Op. Cash FlowCN¥4.4B
Industry P/E16.4
Technical Analysis
TrendBearish
RSI43.7
SupportCN¥4.17
ResistanceCN¥4.47
MA 20CN¥4.33
MA 50CN¥4.37
MA 200CN¥4.37
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88
Valuation
Fair ValueCN¥29.45
GradeOvervalued
TypeValue
Dividend Yield0.59%
Risk Assessment
Beta0.20
Volatility19.92%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.